Literature DB >> 8185474

The spectrum of biliary tract disorders in infants and children. Experience with 300 cases.

J L Grosfeld1, F J Rescorla, M A Skinner, K W West, L R Scherer.   

Abstract

OBJECTIVES: To assess the results of surgical treatment of infants and children with biliary tract disease.
DESIGN: The records of children with biliary tract disorders requiring surgical intervention were reviewed retrospectively. Diagnosis, age, sex, clinical presentation, treatment, and outcome were evaluated.
SETTING: A large pediatric referral facility. PATIENTS: A total of 300 patients treated from 1972 through 1993 were evaluated, including 102 with biliary atresia, 29 with choledochal cyst, and 169 with cholelithiasis. Hepatic portoenterostomy was performed in 87 patients with biliary atresia, and biopsy alone was performed in 15. Twenty girls and nine boys, 50% of whom were younger than 3 years, had choledochal cyst. Operative management included cyst excision and hepatojejunostomy in 25 patients, cyst jejunostomy in two patients, cystduodenostomy in one patient, and choledochocele excision in one patient. Gallstones were observed in 106 girls and 63 boys; 28 were aged 0 to 5 years, 31 were aged 6 to 10 years, and 110 were aged 11 to 18 years. Open cholecystectomy was performed in 143 patients, and laparoscopic cholecystectomy was performed in 26 patients. MAIN OUTCOME MEASURES: Principal outcomes examined were surgical morbidity and mortality.
RESULTS: Hepatic portoenterostomy was successful in 28 (32%) of 87 patients with biliary atresia (all younger than 3 months), and 23 showed improvement following hepatic portoenterostomy; hepatic portoenterostomy failed in 36 patients. Twenty-eight (82.3%) of 34 patients survived liver transplantation. Overall survival was 71.5%. Survival of patients with choledochal cyst was 96.4% (28/29). Cholecystectomy was successful in all 169 patients. There were eight complications and one death (0.59% mortality).
CONCLUSIONS: Survival in patients with biliary atresia (71%) has improved with hepatic portoenterostomy complemented by liver transplantation. Hepatic portoenterostomy is the procedure of choice in infants younger than 3 months. An improved outlook for patients with choledochal cyst can be expected after cyst excision and hepatojejunostomy. Gallstones are relatively common in children. Both open and laparoscopic cholecystectomy are safe and effective procedures in children.

Entities:  

Mesh:

Year:  1994        PMID: 8185474     DOI: 10.1001/archsurg.1994.01420290059009

Source DB:  PubMed          Journal:  Arch Surg        ISSN: 0004-0010


  7 in total

Review 1.  Infant cholelithiasis: report of a case.

Authors:  K Asabe; N Handa
Journal:  Surg Today       Date:  1997       Impact factor: 2.549

2.  Trends in management of gallbladder disorders in children.

Authors:  H L Lugo-Vicente
Journal:  Pediatr Surg Int       Date:  1997-07       Impact factor: 1.827

3.  High rate of complicated idiopathic gallstone disease in pediatric patients of a North American tertiary care center.

Authors:  Denise Herzog; Guylaine Bouchard
Journal:  World J Gastroenterol       Date:  2008-03-14       Impact factor: 5.742

4.  A study of associated congenital anomalies with biliary atresia.

Authors:  Lucky Gupta; Veereshwar Bhatnagar
Journal:  J Indian Assoc Pediatr Surg       Date:  2016 Jan-Mar

5.  Biliary atresia with an unusual abdominal orientation: A case report.

Authors:  Jawad Allarakia; Taher Felemban; Waleed Khayyat; Ahmed Alawi; Abdurrahaman Mirza; Batool Alkhazal; Yasmin Yousef
Journal:  Int J Surg Case Rep       Date:  2019-01-30

6.  Application of narrative nursing in the families of children with biliary atresia: A retrospective study.

Authors:  Liang-Hui Zhang; Hong-Yan Meng; Ren Wang; You-Cheng Zhang; Jian Sun
Journal:  World J Clin Cases       Date:  2021-12-06       Impact factor: 1.337

7.  Fetal choledochal cyst diagnosed at 22 weeks of gestation by three-dimensional ultrasonography: a case report.

Authors:  Il-Han Lee; Gwang-Jun Kim
Journal:  J Korean Med Sci       Date:  2008-10       Impact factor: 2.153

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.